 GARDEN CITY, N.Y., Nov. 19, 2020 GLOBE NEWSWIRE -- Beyond Air, Inc. NASDAQ: XAIR, a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide NO for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO gNO for the treatment of solid tumors, today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in the 32nd Annual Piper Sandler Healthcare Conference being held virtually from December 1-3, 2020. Beyond Air will provide a pre-recorded investor presentation and will be available for virtual one-on-one meetings during the conference. 